Charles Jakobsche

Prof. Charles Jakobsche

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in American Journal of Dance Therapy
Verified
Journal Article
Open access
PDF file
ILIvana Lopez-Nieves
Ivana Lopez-Nieves
CJCharles Jakobsche
Charles Jakobsche
The positive health impacts of dance and dance/movement therapy can be seen all the way down to the molecular level. This narrative-style review illustrates this connection by presenting a collection of clinical and preclinical studies that evaluate the effects of dance activities on hormones and other small-molecule metabolites within the human body. The results of these studies show that dance activities can increase levels of nitric oxide, serotonin, estrogen hormones, and HDL cholesterol, while they can decrease levels of dopamine, serum glucose, serum triglycerides, and LDL cholesterol. Levels of cortisol can either be increased or decreased, depending on the type of dance. Many of these results parallel the biomolecular effects of traditional (non-dance) exercise activities, although some contrasting results can also be seen. The concentrations of these molecules and their distributions throughout the body impact health and a wide variety of disease states. This connection to the molecular level provides a perspective for understanding how it is that dance activities are able to affect larger-scale physiological and psychological responses and lead to the positive health outcomes that are observed in many situations.

1 January 2017 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
ABAshley A. Burke
Ashley A. Burke
ESElizabeth S. Severson
Elizabeth S. Severson
SMShreya Mool
Shreya Mool
MBMaria J. Solares Bucaro
Maria J. Solares Bucaro
FGFrederick T. Greenaway
Frederick T. Greenaway
CJCharles Jakobsche
Charles Jakobsche
Lysyl oxidase has emerged as an important enzyme in cancer metastasis. Its activity has been reported to become upregulated in several types of cancer, and blocking its activity has been shown to limit the metastatic potential of various cancers. The small-molecules phenylhydrazine and β-aminopropionitrile are known to inhibit lysyl oxidase; however, issues of stability, toxicity, and poorly defined mechanisms limit their potential use in medical applications. The experiments presented herein evaluate three other families of hydrazine-derived compounds – hydrazides, alkyl hydrazines, and semicarbazides – as irreversible inhibitors of lysyl oxidase including determining the kinetic parameters and comparing the inhibition selectivities for lysyl oxidase against the topaquinone-containing diamine oxidase from lentil seedlings. The results suggest that the hydrazide group may be a useful core functionality that can be developed into potent and selective inhibitors of lysyl oxidase and eventually find application in cancer metastasis research.

31 October 2018 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
ABAshley A. Burke
Ashley A. Burke
LBLuke Barrows
Luke Barrows
MSMaria J. Solares
Maria J. Solares
AWAlexander D. Wall
Alexander D. Wall
CJCharles Jakobsche
Charles Jakobsche

21 July 2023 in Journal of Chemical Education
Verified
Journal Article
Closed access
CJCharles Jakobsche
Charles Jakobsche
PKPitipat Kongsomjit
Pitipat Kongsomjit
CMConor Milson
Conor Milson
WWWenxing Wang
Wenxing Wang
CNChun-Kit Ngan
Chun-Kit Ngan

25 August 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
QZQiuchen Zheng
Qiuchen Zheng
MKMicheal T. Kebede
Micheal T. Kebede
BLBethany Lee
Bethany Lee
CKClaire A. Krasinski
Claire A. Krasinski
SISaadman Islam
Saadman Islam
NLNoel D. Lazo
Noel D. Lazo
The insulin-degrading enzyme (IDE) possesses a strong ability to degrade insulin and Aβ42 that has been linked to the neurodegeneration in Alzheimer’s disease (AD). Given this, an attractive IDE-centric strategy for the development of therapeutics for AD is to boost IDE’s activity for the clearance of Aβ42 without offsetting insulin proteostasis. Recently, we showed that resveratrol enhances IDE’s activity toward Aβ42. In this work, we used a combination of chromatographic and spectroscopic techniques to investigate the effects of resveratrol on IDE’s activity toward insulin. For comparison, we also studied epigallocatechin-3-gallate (EGCG). Our results show that the two polyphenols affect the IDE-dependent degradation of insulin in different ways: EGCG inhibits IDE while resveratrol has no effect. These findings suggest that polyphenols provide a path for developing therapeutic strategies that can selectively target IDE substrate specificity.

16 June 2015 in Synthetic Communications
Verified
Journal Article
Closed access
NMNicholas S. MacArthur
Nicholas S. MacArthur
LWLinshu Wang
Linshu Wang
BMBlaine G. McCarthy
Blaine G. McCarthy
CJCharles Jakobsche
Charles Jakobsche
The reported rearrangement of N-nitrosodichloroacetamides provides a practicalmethod for converting primary amines into primary alcohols. The reaction sequence is operationally simple, requires only a single purification, and is compatible with a number of common functional groups. Mechanistic studies of the nitrosylation and rearrangement reactions illustrate the increased utility of dichloroacetamides compared to various other amides for this transformation.